Q46624974 | 2,6,10-Tris(dialkylamino)trioxatriangulenium salts: a new promising fluorophore. Ion-pair formation and aggregation in non-polar solvents. |
Q38726594 | 3-Amino-thieno[2,3-b]pyridines as microtubule-destabilising agents: Molecular modelling and biological evaluation in the sea urchin embryo and human cancer cells. |
Q57149545 | A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2-chromen-4-ol Scaffold |
Q90663132 | Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2 |
Q49720564 | Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors. |
Q40050431 | Anti-influenza activity of diazaadamantanes combined with monoterpene moieties |
Q34048477 | Bond stability of the "undesirable" heteroatom-heteroatom molecular moieties for high-throughput screening libraries |
Q91520982 | Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-5 |
Q46905097 | Characterisation of radicals formed by the triazine 1,4-dioxide hypoxia-activated prodrug, SN30000. |
Q51380847 | Coumarin Antifungal Lead Compounds from Millettia thonningii and Their Predicted Mechanism of Action. |
Q43039962 | DFT calculations on the deprotonation site of the one-electron oxidised guanine-cytosine base pair |
Q98202331 | Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1 |
Q60162743 | Development of NMR and thermal shift assays for the evaluation of isocitrate lyase inhibitors |
Q91642873 | Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening |
Q36671457 | Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative |
Q48176143 | Ferrocenyl Paclitaxel and Docetaxel Derivatives: Impact of an Organometallic Moiety on the Mode of Action of Taxanes. |
Q47274809 | GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative Agents. |
Q64268874 | Generation of Quality Hit Matter for Successful Drug Discovery Projects |
Q37712277 | Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound |
Q38910350 | Half-sandwich ruthenium(II) biotin conjugates as biological vectors to cancer cells |
Q46953316 | Hit generation and exploration: imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases |
Q44760687 | Hydrogen bonding between histidine and lignin model compounds or redox mediators as calculated with the DFT method. Effects on the ease of oxidation |
Q91254000 | Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90) |
Q38765080 | Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds |
Q27662513 | Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate |
Q38357617 | Intercalation of trioxatriangulenium ion in DNA: binding, electron transfer, x-ray crystallography, and electronic structure. |
Q47720805 | Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents. |
Q33359104 | Investigation of the incidence of "undesirable" molecular moieties for high-throughput screening compound libraries in marketed drug compounds |
Q42733678 | Molecular mechanism of base pairing infidelity during DNA duplication upon one-electron oxidation |
Q46489626 | Mutagenic potential of nitrenium ions of nitrobenzanthrones: correlation between theory and experiment |
Q39796289 | Mutagenicity and DNA adduct formation by the urban air pollutant 2-nitrobenzanthrone |
Q48206344 | New Anti-Seizure (Arylalkyl)azole Derivatives: Synthesis, In Vivo and In Silico Studies. |
Q48172023 | New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity |
Q51473584 | New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties. |
Q52644553 | Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. |
Q33507355 | One-electron reduction of 2-aminopurine in the aqueous phase. A DFT and pulse radiolysis study |
Q33267467 | Photoionization versus photoheterolysis of all-trans-retinol. The effects of solvent and laser radiation intensity |
Q44375445 | Photophysics of trioxatriangulenium ion. electrophilic reactivity in the ground state and excited singlet state. |
Q31112620 | Radical Chemistry and Cytotoxicity of Bioreductive 3-Substituted Quinoxaline Di-N-Oxides |
Q40368701 | Serendipity in anticancer drug discovery |
Q47321477 | Size estimation of chemical space: how big is it? |
Q27664427 | Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells |
Q51260441 | Synthesis and antiproliferative activity of 2-chlorophenyl carboxamide thienopyridines. |
Q38300174 | Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety |
Q38959142 | Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives |
Q38795823 | Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives. |
Q46302107 | Synthesis and in vitro Biological Evaluation of Ferrocenyl Side-Chain-Functionalized Paclitaxel Derivatives. |
Q47196925 | Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action |
Q47159745 | Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action† †Electronic supplementary information (ESI) available: Experimental, crystallographic, biological and mass spectrometric data, full list of pr |
Q57804631 | The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening |
Q100392868 | The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme |
Q99579575 | The cytotoxic potential of cationic triangulenes against tumour cells |
Q39331377 | The effect of PLC-γ2 inhibitors on the growth of human tumour cells |
Q39870054 | The identification of novel PLC-gamma inhibitors using virtual high throughput screening |
Q43504556 | The physicochemical properties of a new class of anticancer fungal polysaccharides: a comparative study |
Q45232748 | Tuning of hydrogen bond strength using substituents on phenol and aniline: a possible ligand design strategy |
Q112575813 | Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs |
Q38787832 | Virtual screening and biophysical studies lead to HSP90 inhibitors. |
Q36091191 | Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study |